{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:04:23Z","timestamp":1747181063577,"version":"3.40.5"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,16]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Crescent formation is rare in primary membranous nephropathy (MN). The mechanism of crescent formation is unknown and the treatments are tentative.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 71-year-old woman presented with nephrotic syndrome, hematuria, and rapidly progressive kidney dysfunction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Kidney biopsy was performed, and the diagnosis was MN in combination with crescentic glomerulonephritis. Circulating anti-PLA2R was detected of a high level.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient received rituximab besides corticosteroids.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient achieved complete remission of proteinuria and recovery of kidney function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our case suggests that there is a pathologic feature of MN and crescents in the absence of known immunologic factors as well as rituximab could serve as an effective cure and could be considered in serious MN conditions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000030663","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T13:03:22Z","timestamp":1663592602000},"page":"e30663","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of membranous nephropathy with crescent nephritis by rituximab: A case report"],"prefix":"10.1097","volume":"101","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nephrology and Laboratory of Kidney Disease, Hunan Provincial People\u2019s Hospital, Hunan Normal University, Changsha, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiya","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Laboratory of Kidney Disease, Hunan Provincial People\u2019s Hospital, Hunan Normal University, Changsha, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinyin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Laboratory of Kidney Disease, Hunan Provincial People\u2019s Hospital, Hunan Normal University, Changsha, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Laboratory of Kidney Disease, Hunan Provincial People\u2019s Hospital, Hunan Normal University, Changsha, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Laboratory of Kidney Disease, Hunan Provincial People\u2019s Hospital, Hunan Normal University, Changsha, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Laboratory of Kidney Disease, Hunan Provincial People\u2019s Hospital, Hunan Normal University, Changsha, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8345-7748","authenticated-orcid":false,"given":"Xun","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Laboratory of Kidney Disease, Hunan Provincial People\u2019s Hospital, Hunan Normal University, Changsha, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/MNH.0b013e3283522ea8","article-title":"The pathogenesis of membranous nephropathy: evolution and revolution.","volume":"21","author":"Glassock","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/S0140-6736(15)60731-0","article-title":"Pathophysiological advances in membranous nephropathy: time for a shift in patient\u2019s care.","volume":"385","author":"Ronco","year":"2015","journal-title":"Lancet (London, England)"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.ajkd.2010.01.008","article-title":"The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey.","volume":"56","author":"Glassock","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy.","volume":"12","author":"Couser","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1681\/ASN.2009121220","article-title":"Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy.","volume":"21","author":"Ronco","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy.","volume":"23","author":"Hofstra","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.12659\/MSM.917732","article-title":"Anti-phospholipase A2 receptor (anti-PLA2R) antibody in diagnosis and treatment of idiopathic membranous nephropathy: a single-center observational study in China.","volume":"25","author":"Guo","year":"2019","journal-title":"Med Sci Monit"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/ckj\/sfy005","article-title":"Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy.","volume":"12","author":"Rodas","year":"2019","journal-title":"Clin Kidney J"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0272-6386(88)80079-9","article-title":"Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy.","volume":"11","author":"Couser","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"e15303","DOI":"10.1097\/MD.0000000000015303","article-title":"Plasma exchange and rituximab treatments in primary membranous nephropathy combined with crescentic glomerulonephritis: a case report.","volume":"98","author":"Lu","year":"2019","journal-title":"Medicine"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.ajkd.2014.02.018","article-title":"Membranous nephropathy with crescents: a series of 19 cases.","volume":"64","author":"Rodriguez","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s11255-013-0593-x","article-title":"Membranous glomerulonephritis with crescents.","volume":"46","author":"Barrett","year":"2014","journal-title":"Int Urol Nephrol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:44:59Z","timestamp":1746333899000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":13,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030663","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,9,16]]}}}